Trial record 2 of 14 for:    NY-ESO-1/LAGE-1

Autologous T Cells Expressing Enhanced TCRs Specific for NYESO-1/LAGE in Patients With Ovarian Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Adaptimmune
Sponsor:
Information provided by (Responsible Party):
Adaptimmune
ClinicalTrials.gov Identifier:
NCT01567891
First received: March 16, 2012
Last updated: June 27, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)